{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T23:45:55Z","timestamp":1776469555531,"version":"3.51.2"},"reference-count":56,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,12]],"date-time":"2021-07-12T00:00:00Z","timestamp":1626048000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Women's Dermatology"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.ijwd.2021.07.002","type":"journal-article","created":{"date-parts":[[2021,7,17]],"date-time":"2021-07-17T15:47:48Z","timestamp":1626536868000},"page":"769-773","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"PB","title":["Art of prevention: The importance of dermatologic care when using aromatase inhibitors"],"prefix":"10.1097","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9159-4745","authenticated-orcid":false,"given":"Sara","family":"Behbahani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amaris","family":"Geisler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4071-6092","authenticated-orcid":false,"given":"Avani","family":"Kolla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6163-4803","authenticated-orcid":false,"given":"Margaret Rush","family":"Dreker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Genevieve","family":"Kaunitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miriam K.","family":"Pomeranz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"10.1016\/j.ijwd.2021.07.002_bib0001","doi-asserted-by":"crossref","first-page":"18334","DOI":"10.1038\/s41598-020-75059-9","article-title":"Increased estrogen to androgen ratio enhances immunoglobulin levels and impairs B cell function in male mice","volume":"10","author":"Aguilar-Pimentel","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.ijwd.2021.07.002_bib0002","doi-asserted-by":"crossref","first-page":"R283","DOI":"10.1530\/ERC-17-0425","article-title":"Acquired resistance to aromatase inhibitors: Where we stand!","volume":"25","author":"Augusto","year":"2018","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.ijwd.2021.07.002_bib0003","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.jaad.2010.06.051","article-title":"The emergence of supportive oncodermatology: The study of dermatologic adverse events to cancer therapies","volume":"65","author":"Balagula","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ijwd.2021.07.002_bib0004","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.clbc.2017.05.008","article-title":"Vaginal atrophy in breast cancer survivors: Attitude and approaches among oncologists","volume":"17","author":"Biglia","year":"2017","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.ijwd.2021.07.002_bib0005","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.clbc.2015.06.005","article-title":"Genitourinary syndrome of menopause in breast cancer survivors: Are we facing new and safe hopes?","volume":"15","author":"Biglia","year":"2015","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.ijwd.2021.07.002_bib0006","first-page":"709","article-title":"Effects of aminoglutethimide plus hydrocortisone on the genital tract of postmenopausal women with advanced breast cancer. A clinical and cytologic survey","volume":"6","author":"Budel","year":"1986","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ijwd.2021.07.002_bib0007","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1093\/annonc\/mdg444","article-title":"Alopecia in a premenopausal breast cancer woman treated with letrozole and triptorelin","volume":"14","author":"Carlini","year":"2003","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijwd.2021.07.002_bib0009","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.3899\/jrheum.080648","article-title":"Accelerated cutaneous nodulosis associated with aromatase inhibitor therapy in a patient with rheumatoid arthritis","volume":"36","author":"Chao","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ijwd.2021.07.002_bib0010","doi-asserted-by":"crossref","first-page":"493","DOI":"10.2147\/IJWH.S69907","article-title":"Clinical utilities of aromatase inhibitors in breast cancer","volume":"7","author":"Chumsri","year":"2015","journal-title":"Int J Womens Health"},{"key":"10.1016\/j.ijwd.2021.07.002_bib0011","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/annonc\/mdl350","article-title":"Henoch-Sch\u00f6nlein purpura (HSP) during treatment with anastrozole","volume":"18","author":"Conti-Beltraminelli","year":"2007","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijwd.2021.07.002_bib0012","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1097\/GME.0000000000000926","article-title":"Missing documentation in breast cancer survivors: genitourinary syndrome of menopause","volume":"24","author":"Cook","year":"2017","journal-title":"Menopause"},{"key":"10.1016\/j.ijwd.2021.07.002_bib0013","first-page":"175","article-title":"Grover disease (transient acantholytic dermatosis) induced by anastrozole","volume":"88","author":"Crockett","year":"2011","journal-title":"Cutis"},{"key":"10.1016\/j.ijwd.2021.07.002_bib0014","doi-asserted-by":"crossref","first-page":"A460","DOI":"10.1016\/j.autrev.2011.11.014","article-title":"Estrogen metabolism and autoimmunity","volume":"11","author":"Cutolo","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.ijwd.2021.07.002_bib0015","first-page":"27","article-title":"Efficacy of a global supportive skin care programme with hydrotherapy after non-metastatic breast cancer treatment: A randomised, controlled study","author":"Dalenc","year":"2018","journal-title":"Eur J Cancer Care (Engl)"},{"key":"10.1016\/j.ijwd.2021.07.002_bib0016","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S1470-2045(18)30116-5","article-title":"Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): A randomised, phase 3 trial","volume":"19","author":"De Placido","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijwd.2021.07.002_bib0017","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1097\/GME.0000000000001121","article-title":"Management of genitourinary syndrome of menopause in women with or at high risk for breast cancer: Consensus recommendations from The North American Menopause Society and The International Society for the Study of Women's Sexual Health","volume":"25","author":"Faubion","year":"2018","journal-title":"Menopause"},{"key":"10.1016\/j.ijwd.2021.07.002_bib0018","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ijwd.2019.10.003","article-title":"Dermatologic conditions in women receiving systemic cancer therapy","volume":"5","author":"Ferreira","year":"2019","journal-title":"Int J Womens Dermatol"},{"key":"10.1016\/j.ijwd.2021.07.002_bib0019","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1001\/jamadermatol.2018.0454","article-title":"Endocrine therapy-induced alopecia in patients with breast cancer","volume":"154","author":"Freites-Martinez","year":"2018","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ijwd.2021.07.002_bib0020","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.jaad.2018.03.055","article-title":"Hair disorders in patients with cancer","volume":"80","author":"Freites-Martinez","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ijwd.2021.07.002_bib0021","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s10549-007-9518-7","article-title":"Erythema nodosum secondary to aromatase inhibitor use in breast cancer patients: Case reports and review of the literature","volume":"106","author":"Jhaveri","year":"2007","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ijwd.2021.07.002_bib0022","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1186\/s40064-016-2216-3","article-title":"Management of hair loss associated with endocrine therapy in patients with breast cancer: An overview","volume":"5","author":"Karatas","year":"2016","journal-title":"Springerplus"},{"key":"10.1016\/j.ijwd.2021.07.002_bib0023","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202000081","article-title":"Aromatase inhibitors: Role in postmenopausal breast cancer","volume":"353","author":"Kharb","year":"2020","journal-title":"Arch Pharm (Weinheim)"},{"key":"10.1016\/j.ijwd.2021.07.002_bib0024","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s40257-018-0384-3","article-title":"Toxic side effects of targeted therapies and immunotherapies affecting the skin, oral mucosa, hair, and nails","volume":"19","author":"Lacouture","year":"2018","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.ijwd.2021.07.002_bib0025","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0093-7754(03)00305-1","article-title":"Pharmacokinetics of third-generation aromatase inhibitors","volume":"30","author":"L\u00f8nning","year":"2003","journal-title":"Semin Oncol"},{"key":"10.1016\/j.ijwd.2021.07.002_bib0026","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jdcr.2015.01.008","article-title":"Eruptive keloids associated with aromatase inhibitor therapy","volume":"1","author":"Meade","year":"2015","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.ijwd.2021.07.002_bib0027","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1007\/s00404-011-2181-6","article-title":"Vaginal estrogen therapy in postmenopausal breast cancer patients treated with aromatase inhibitors","volume":"285","author":"Moegele","year":"2012","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.ijwd.2021.07.002_bib0028","doi-asserted-by":"crossref","first-page":"469","DOI":"10.5301\/tj.5000376","article-title":"Adjuvant aromatase inhibitor therapy in early breast cancer: What factors lead patients to discontinue treatment?","volume":"101","author":"Moscetti","year":"2015","journal-title":"Tumori"},{"key":"10.1016\/j.ijwd.2021.07.002_bib0029","doi-asserted-by":"crossref","first-page":"AB209","DOI":"10.1016\/j.jaad.2019.06.768","article-title":"Exemestane induced leukocytoclastic vasculitis presenting as pseudocellulitis","volume":"81","author":"Ooi","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ijwd.2021.07.002_bib0030","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1093\/annonc\/mdg362","article-title":"Mature results of a randomized phase II multicenter study of exemestane versus tamoxifen as first-line hormone therapy for postmenopausal women with metastatic breast cancer","volume":"14","author":"Paridaens","year":"2003","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijwd.2021.07.002_bib0031","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ijscr.2015.09.024","article-title":"Letrozole-induced necrotising leukocytoclastic small vessel vasculitis: First report of a case in the UK","volume":"16","author":"Pathmarajah","year":"2015","journal-title":"Int J Surg Case Rep"},{"key":"10.1016\/j.ijwd.2021.07.002_bib0032","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1684\/ejd.2009.0745","article-title":"Henoch-Sch\u00f6nlein purpura and aromatase inhibitors","volume":"19","author":"Pellegrini","year":"2009","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.ijwd.2021.07.002_bib0033","series-title":"Aromatase inhibitors","author":"Peters","year":"2020"},{"key":"10.1016\/j.ijwd.2021.07.002_bib0034","doi-asserted-by":"crossref","first-page":"e168","DOI":"10.3747\/co.25.3735","article-title":"Aromatase inhibitors in premenopausal women with breast cancer: The state of the art and future prospects","volume":"25","author":"Pistelli","year":"2018","journal-title":"Curr Oncol"},{"key":"10.1016\/j.ijwd.2021.07.002_bib0035","doi-asserted-by":"crossref","first-page":"126","DOI":"10.5606\/ArchRheumatol.2014.3429","article-title":"Letrozole-induced very early systemic sclerosis in a patient with breast cancer: A case report","volume":"29","author":"Pokhai","year":"2014","journal-title":"Arch Rheumatol"},{"key":"10.1016\/j.ijwd.2021.07.002_bib0036","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1007\/s11606-012-2209-z","article-title":"Lichen sclerosus in a breast cancer survivor on an aromatase inhibitor: A case report","volume":"28","author":"Potter","year":"2013","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.ijwd.2021.07.002_bib0037","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1093\/annonc\/mdt170","article-title":"Aromatase inhibitors induce 'male pattern hair loss' in women?","volume":"24","author":"Rossi","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijwd.2021.07.002_bib0039","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1210\/er.2008-0016","article-title":"History of aromatase: Saga of an important biological mediator and therapeutic target","volume":"30","author":"Santen","year":"2009","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ijwd.2021.07.002_bib0040","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/j.1468-3083.2010.03803.x","article-title":"Aromatase inhibitor-induced skin adverse reactions: Exemestane-related cutaneous vasculitis","volume":"25","author":"Santoro","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ijwd.2021.07.002_bib0041","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.jdcr.2018.05.007","article-title":"Two cases of treatment with aromatase inhibitors and development of miliary osteoma cutis\u2014Is there an association?","volume":"4","author":"Schadler","year":"2018","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.ijwd.2021.07.002_bib0042","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/S1470-2045(14)71035-6","article-title":"Changes in bone mineral density at 3 years in postmenopausal women receiving anastrozole and risedronate in the IBIS-II bone substudy: An international, double-blind, randomised, placebo-controlled trial","volume":"15","author":"Sestak","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijwd.2021.07.002_bib0043","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1136\/ard.2004.023150","article-title":"Cutaneous vasculitis developed in a patient with breast cancer undergoing aromatase inhibitor treatment","volume":"64","author":"Shoda","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ijwd.2021.07.002_bib0044","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s10549-017-4523-y","article-title":"Ribociclib with letrozole vs letrozole alone in elderly patients with hormone receptor-positive, HER2-negative breast cancer in the randomized MONALEESA-2 trial","volume":"167","author":"Sonke","year":"2018","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ijwd.2021.07.002_bib0045","first-page":"1381","article-title":"Preliminary study of the treatment of advanced breast cancer in postmenopausal women with the aromatase inhibitor CGS 16949A","volume":"50","author":"Stein","year":"1990","journal-title":"Cancer Res"},{"key":"10.1016\/j.ijwd.2021.07.002_bib0046","first-page":"2589","article-title":"Capillaritis (purpura simplex) associated with use of aminoglutethimide in Cushing's syndrome","volume":"51","author":"Stratakis","year":"1994","journal-title":"Am J Hosp Pharm"},{"key":"10.1016\/j.ijwd.2021.07.002_bib0047","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1200\/JOP.18.00710","article-title":"Managing genitourinary syndrome of menopause in breast cancer survivors receiving endocrine therapy","volume":"15","author":"Sussman","year":"2019","journal-title":"J Oncol Pract"},{"key":"10.1016\/j.ijwd.2021.07.002_bib0048","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1093\/annonc\/mdg014","article-title":"Double-blind randomised trial comparing the non-steroidal aromatase inhibitors letrozole and fadrozole in postmenopausal women with advanced breast cancer","volume":"14","author":"Tominaga","year":"2003","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijwd.2021.07.002_bib0049","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/j.1365-2133.2007.08367.x","article-title":"Anastrozole-induced subacute cutaneous lupus erythematosus","volume":"158","author":"Trancart","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ijwd.2021.07.002_bib0050","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1001\/jamadermatol.2018.0453","article-title":"Minoxidil for endocrine therapy-induced alopecia in women with breast cancer-Saint Agatha's blessing?","volume":"154","author":"Tr\u00fceb","year":"2018","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ijwd.2021.07.002_bib0051","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ejca.2015.10.012","article-title":"A European Organisation for Research and Treatment of Cancer randomized, double-blind, placebo-controlled, multicentre phase II trial of anastrozole in combination with gefitinib or placebo in hormone receptor-positive advanced breast cancer (NCT00066378)","volume":"53","author":"Tryfonidis","year":"2016","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ijwd.2021.07.002_bib0052","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.jaad.2014.12.010","article-title":"Incidence and risk of xerosis with targeted anticancer therapies","volume":"72","author":"Valentine","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ijwd.2021.07.002_bib0053","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1259\/0007-1285-60-720-1226","article-title":"Skin reaction following aminoglutethimide and radiotherapy","volume":"60","author":"Williams","year":"1987","journal-title":"Br J Radiol"},{"key":"10.1016\/j.ijwd.2021.07.002_bib0054","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1634\/theoncologist.2010-0435","article-title":"Topical testosterone for breast cancer patients with vaginal atrophy related to aromatase inhibitors: A phase I\/II study","volume":"16","author":"Witherby","year":"2011","journal-title":"Oncologist"},{"key":"10.1016\/j.ijwd.2021.07.002_bib0055","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.clim.2008.07.001","article-title":"La Cava A. Cutaneous vasculitis in breast cancer treated with chemotherapy","volume":"129","author":"Wong","year":"2008","journal-title":"Clin Immunol"},{"key":"10.1016\/j.ijwd.2021.07.002_bib0056","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1111\/imj.14422","article-title":"Leukocytoclastic vasculitis associated with use of aromatase inhibitors","volume":"49","author":"Woodford","year":"2019","journal-title":"Intern Med J"},{"key":"10.1016\/j.ijwd.2021.07.002_bib0057","doi-asserted-by":"crossref","first-page":"129","DOI":"10.4103\/ds.ds_4_20","article-title":"Lupus erythematosus\/lichen planus overlap syndrome in a breast cancer patient receiving aromatase inhibitor: A case report and review of the literature","volume":"38","author":"Yang","year":"2020","journal-title":"Dermatologica Sinica"},{"key":"10.1016\/j.ijwd.2021.07.002_bib0058","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jare.2016.04.001","article-title":"Aromatase inhibitors induced autoimmune disorders in patients with breast cancer: A review","volume":"7","author":"Zarkavelis","year":"2016","journal-title":"J Adv Res"}],"container-title":["International Journal of Women's Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352647521000812?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352647521000812?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,1,7]],"date-time":"2022-01-07T14:28:17Z","timestamp":1641565697000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352647521000812"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":56,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S2352647521000812"],"URL":"https:\/\/doi.org\/10.1016\/j.ijwd.2021.07.002","relation":{},"ISSN":["2352-6475"],"issn-type":[{"value":"2352-6475","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Art of prevention: The importance of dermatologic care when using aromatase inhibitors","name":"articletitle","label":"Article Title"},{"value":"International Journal of Women's Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijwd.2021.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc. on behalf of Women's Dermatologic Society.","name":"copyright","label":"Copyright"}]}}